Vivos Therapeutics Stock Today
| VVOS Stock | USD 3.52 0.01 0.28% |
PerformanceVery Weak
| Odds Of DistressVery High
|
Vivos Therapeutics is selling for under 3.52 as of the 20th of March 2025; that is 0.28 percent decrease since the beginning of the trading day. The stock's lowest day price was 3.41. Vivos Therapeutics has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 20th of December 2024 and ending today, the 20th of March 2025. Click here to learn more.
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea , and snoring in adults. Vivos Therapeutics, Inc. was founded in 2016 and is based in Highlands Ranch, Colorado. The company has 5.89 M outstanding shares of which 281.73 K shares are at this time shorted by private and institutional investors with about 1.87 trading days to cover. More on Vivos Therapeutics
Moving against Vivos Stock
Vivos Stock Highlights
| Thematic Idea | Medical Equipment (View all Themes) |
| Business Concentration | Medical Equipment, Medical Devices, Healthcare, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) |
Vivos Therapeutics (VVOS) is traded on NASDAQ Exchange in USA. It is located in 7921 Southpark Plaza, Littleton, CO, United States, 80120 and employs 114 people. Vivos Therapeutics is listed under Medical Equipment category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 20.79 M. Vivos Therapeutics conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 5.89 M outstanding shares of which 281.73 K shares are at this time shorted by private and institutional investors with about 1.87 trading days to cover.
Vivos Therapeutics currently holds about 17.83 M in cash with (11.95 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.77.
Check Vivos Therapeutics Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Vivos Therapeutics is $20.79 Million. Vivos Therapeutics has 8.0 % of its outstanding shares held by insiders and 13.7 % owned by institutional holders. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Vivos Ownership Details
Vivos Therapeutics Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Vivos Therapeutics market risk premium is the additional return an investor will receive from holding Vivos Therapeutics long position in a well-diversified portfolio.
| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.41) | |||
| Total Risk Alpha | 0.0769 | |||
| Treynor Ratio | (5.36) |
Vivos Stock Against Markets
Vivos Therapeutics Corporate Management
| RaeAnn Byrnes | CoFounder Services | Profile | |
| Kirk Huntsman | Chairman CoFounder | Profile | |
| Julie Gannon | Chief Relations | Profile | |
| Nicholas DeGennaro | Senior Division | Profile | |
| John Ballard | Senior Technology | Profile | |
| Ruth Hembree | Senior Services | Profile | |
| Todd Huntsman | CoFounder Technology | Profile |
Additional Tools for Vivos Stock Analysis
When running Vivos Therapeutics' price analysis, check to measure Vivos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vivos Therapeutics is operating at the current time. Most of Vivos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Vivos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vivos Therapeutics' price. Additionally, you may evaluate how the addition of Vivos Therapeutics to your portfolios can decrease your overall portfolio volatility.